50581 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 19
14:33 UTC
|
GPN
Global Payments
|
◎ Target | Daniel R. Perlin not yet tracked | Sec→ r Perform | $96.00→ $102.00+6.2% |
|
Aug 19
14:33 UTC
|
GPI
Group 1 Automotive
|
◎ Target | John Babcock ★★★☆☆ #2178 | Overweight | $435.00→ $365.00-16.1% |
|
Aug 19
14:33 UTC
|
EQH
Equitable
|
◎ Target | Wesley Carmichael ★★★★☆ #393 | Overweight | $60.00→ $64.00+6.7% |
|
Aug 19
14:33 UTC
|
CVS
CVS Health
|
◎ Target | Steve Silver not yet tracked | Buy | $104.00→ $114.00+9.6% |
|
Aug 19
14:33 UTC
|
COP
ConocoPhillips
|
◎ Target | Bill Selesky ★★★☆☆ #1080 | Buy | $136.00→ $153.00+12.5% |
|
Aug 19
14:33 UTC
|
COLL
Collegium Pharmaceutical
|
◎ Target | Glen Santangelo ★★★★☆ #848 | Overweight | $56.00→ $48.00-14.3% |
|
Aug 19
14:33 UTC
|
BIDU
Baidu
|
◎ Target | Jiong Shao ★☆☆☆☆ #2973 | Equal Weight | $124.00→ $96.00-22.6% |
|
Aug 19
14:33 UTC
|
BALY
Bally's
|
◎ Target | Brandt Montour ★★★☆☆ #2028 | Underweight | $8.00→ $7.00-12.5% |
|
Aug 19
14:33 UTC
|
AS
Amer Sports
|
◎ Target | Adrienne Yih ★★★☆☆ #1640 | Overweight | $49.00→ $50.00+2.0% |
|
Aug 19
14:33 UTC
|
AS
Amer Sports
|
◎ Target | Joseph Civello ★★★☆☆ #2171 | Buy | $50.00→ $42.00-16.0% |
|
Aug 19
14:33 UTC
|
ARMK
Aramark
|
◎ Target | Karl Green not yet tracked | Outperform | $60.00→ $70.00+16.7% |
|
Aug 19
14:33 UTC
|
APP
AppLovin
|
◎ Target | Alec Brondolo ★★★☆☆ #1984 | Equal Weight | $357.00→ $325.00-9.0% |
|
Aug 19
14:33 UTC
|
AMLX
Amylyx Pharmaceuticals
|
◎ Target | Seamus Fernandez ★★★☆☆ #1833 | Buy | $40.00→ $55.00+37.5% |
|
Aug 19
14:33 UTC
|
AMGN
Amgen
|
◎ Target | Jasper Hellweg ★★★★☆ #742 | Buy | $375.00→ $460.00+22.7% |
|
Aug 19
14:33 UTC
|
SU
Suncor Energy
|
↑ Upgrade | firm only | Equal Weight→ Overweight | |
|
Aug 19
13:33 UTC
|
USAS
Americas Gold and Silver
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $9.75→ $9.25-5.1% |
|
Aug 19
13:33 UTC
|
RYAN
Ryan Specialty
|
◎ Target | Bob Huang ★★★★☆ #474 | Overweight | $48.00→ $50.00+4.2% |
|
Aug 19
13:33 UTC
|
RCEL
Avita Medical
|
◎ Target | Ryan Zimmerman ★★★☆☆ #1728 | Buy | $7.00→ $11.00+57.1% |
|
Aug 19
13:33 UTC
|
ONCY
Oncolytics Biotech
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $5.00 |
|
Aug 19
13:33 UTC
|
KEYS
Keysight Technologies
|
◎ Target | Mehdi Hosseini ★★★☆☆ #1102 | Positive | $425.00→ $440.00+3.5% |
|
Aug 19
13:33 UTC
|
CRBG
Corebridge Financial
|
◎ Target | Wesley Carmichael ★★★★☆ #393 | Overweight | $36.00→ $39.00+8.3% |
|
Aug 19
13:33 UTC
|
AON
AON
|
◎ Target | Michael Phillips not yet tracked | Overweight | $380.00→ $410.00+7.9% |
|
Aug 19
13:33 UTC
|
AHR
American Healthcare REIT
|
◎ Target | Austin Wurschmidt ★★★☆☆ #1451 | Overweight | $58.00→ $68.00+17.2% |
|
Aug 19
13:33 UTC
|
PS
Pershing Square
|
↓ Downgrade | Matthew Heimermann ★★★★★ #170 | Buy→ Neutral | $45.00 |
|
Aug 19
13:33 UTC
|
MD
Pediatrix Medical Group
|
↓ Downgrade | Jack Slevin ★★★★★ #51 | Buy→ Hold | $27.00→ $28.00+3.7% |
|
Aug 19
13:33 UTC
|
CME
CME Group
|
↓ Downgrade | firm only | Buy→ Hold | $270.00 |
|
Aug 19
13:33 UTC
|
MRNA
Moderna
|
↑ Upgrade | firm only | Market Perform→ Outperform | |
|
Aug 19
13:33 UTC
|
FN
Fabrinet
|
↑ Upgrade | firm only | Equal Weight→ Overweight | |
|
Aug 19
13:33 UTC
|
D
Dominion Energy
|
↑ Upgrade | firm only | Hold→ Buy | $80.00 |
|
Aug 19
13:33 UTC
|
CIEN
Ciena
|
↑ Upgrade | Tim Savageaux ★★☆☆☆ #2676 | Market Perform→ Outperform | $450.00→ $500.00+11.1% |
|
Aug 19
13:33 UTC
|
APA
APA
|
↑ Upgrade | Bill Selesky ★★★☆☆ #1080 | Hold→ Buy | $48.00 |
|
Aug 19
12:33 UTC
|
WTW
Willis Towers Watson Public
|
◎ Target | Vincent Sinisi not yet tracked | Equal Weight | $315.00→ $350.00+11.1% |
|
Aug 19
12:33 UTC
|
THG
The Hanover Insurance Group
|
◎ Target | Bob Huang ★★★★☆ #474 | Equal Weight | $235.00→ $240.00+2.1% |
|
Aug 19
12:33 UTC
|
PANW
Palo Alto Networks
|
◎ Target | Jonathan Ruykhaver ★★★★★ #88 | Overweight | $340.00→ $425.00+25.0% |
|
Aug 19
12:33 UTC
|
MTB
M&T Bank
|
◎ Target | Dave Rochester ★★★☆☆ #1161 | Overweight | $262.00→ $285.00+8.8% |
|
Aug 19
12:33 UTC
|
MRSH
Marsh & McLennan Companies
|
◎ Target | Bob Huang ★★★★☆ #474 | Equal Weight | $180.00→ $200.00+11.1% |
|
Aug 19
12:33 UTC
|
MRCY
Mercury Systems
|
◎ Target | Peter Arment ★★☆☆☆ #2880 | Outperform | $120.00→ $130.00+8.3% |
|
Aug 19
12:33 UTC
|
LOB
Live Oak Bancshares
|
◎ Target | Dave Rochester ★★★☆☆ #1161 | Neutral | $44.00→ $45.00+2.3% |
|
Aug 19
12:33 UTC
|
LMND
Lemonade
|
◎ Target | Bob Huang ★★★★☆ #474 | Equal Weight | $65.00→ $56.00-13.8% |
|
Aug 19
12:33 UTC
|
LFST
LifeStance Health Group
|
◎ Target | David Larsen ★★★★☆ #427 | Buy | $16.00→ $18.00+12.5% |
|
Aug 19
12:33 UTC
|
KNSL
Kinsale Capital Group
|
◎ Target | Bob Huang ★★★★☆ #474 | Equal Weight | $345.00→ $390.00+13.0% |
|
Aug 19
12:33 UTC
|
KEYS
Keysight Technologies
|
◎ Target | Richard Eastman not yet tracked | Outperform | $385.00→ $410.00+6.5% |
|
Aug 19
12:33 UTC
|
HSIC
Henry Schein
|
◎ Target | David Larsen ★★★★☆ #427 | Buy | $100.00→ $110.00+10.0% |
|
Aug 19
12:33 UTC
|
HOMB
Home BancShares
|
◎ Target | Dave Rochester ★★★☆☆ #1161 | Neutral | $30.00→ $31.00+3.3% |
|
Aug 19
12:33 UTC
|
HG
Hamilton Insurance Group
|
◎ Target | Bob Huang ★★★★☆ #474 | Equal Weight | $34.00→ $37.00+8.8% |
|
Aug 19
12:33 UTC
|
DCI
Donaldson
|
◎ Target | Richard Eastman not yet tracked | Outperform | $95.00→ $105.00+10.5% |
|
Aug 19
12:33 UTC
|
CYPH
Cypherpunk Technologies
|
◎ Target | Nathan Frankovitz not yet tracked | Overweight | $0.90→ $1.60+77.8% |
|
Aug 19
12:33 UTC
|
CTRI
Centuri
|
◎ Target | Manish A. Somaiya not yet tracked | Overweight | $35.00→ $36.00+2.9% |
|
Aug 19
12:33 UTC
|
CFR
Cullen/Frost Bankers
|
◎ Target | Dave Rochester ★★★☆☆ #1161 | Neutral | $158.00→ $175.00+10.8% |
|
Aug 19
12:33 UTC
|
CFG
Citizens Financial Group
|
◎ Target | Dave Rochester ★★★☆☆ #1161 | Overweight | $80.00→ $84.00+5.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.